A 28-year-old woman with newly diagnosed pulmonary tuberculosis is found to be resistant to isoniazid and rifampicin on drug susceptibility testing. She has no history of prior TB treatment. What is the drug of choice for initiating second-line therapy in this patient with MDR-TB (multidrug-resistant tuberculosis)?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.